Sexually transmitted disease diagnostics market booming with an average annual growth rate of 7.9% and expected to reach $6.4 billion by 2032 | FMI

Sexually transmitted disease diagnostics market

The sexually transmitted disease diagnostics market is experiencing a boom, driven by rising STD rates and advances in diagnostic technology. According to a new industry report, the market is poised to record a staggering 6.4 billion US dollars by 2032, which corresponds to a robust average annual growth rate (CAGR) of 7.9% from 2022. This upward trend represents a significant increase in 3.8 billion US dollars in 2022 and underscores the promising future of the STD diagnostics industry.

One of the major reasons for this expected increase is the increasing number of government initiatives that raise awareness about STDs and promote early detection and treatment. These proactive efforts have significantly contributed to an increased demand for advanced diagnostic solutions, thereby boosting the growth of the STD diagnostics market.

Furthermore, the industry has experienced a transformative impact with the advent of innovative technologies such as molecular diagnostics, point-of-care testing, and nucleic acid amplification tests (NAATs). These breakthroughs have not only improved the accuracy of STD diagnosis but have also accelerated the testing process, leading to further acceleration in market growth.

In sexually transmitted disease diagnostic tests, the market is segmented into tests for chlamydia, syphilis, gonorrhea, herpes simplex virus, human papillomavirus and human immunodeficiency virus.

Request a sample of this report now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-14744

The major players in the sexually transmitted disease diagnostics market are:

1. Abbott Laboratories
2. Bio-Rad Labs
3. Qaigen Inc.
4. Diasorin SPA
5. MedMira Inc.
6. Hoffman
7. Hologic
8. Cepheids
9. BioMeriuex

The growth of the global sexually transmitted disease diagnostics industry is expected to be driven by several factors, including the increasing prevalence of sexually transmitted diseases worldwide, raising patient awareness through educational campaigns and government initiatives.

The prevalence and cases of sexually transmitted diseases have increased significantly over the last decade. Given the increasing prevalence, many countries are focusing on expanding the coverage of sexually transmitted disease diagnosis by implementing national screening programs. Payment terms for these services are also favorable. Due to these factors, the number of tests for sexually transmitted diseases is increasing worldwide.

Sexually Transmitted Disease Diagnostics Market – KEY FINDINGS:

• The market for sexually transmitted disease diagnostics is expected to grow at a compound annual growth rate of 7.2% until 2032 in the laboratory testing section of the “Diagnostic testing site” category.
• The average annual growth rate for the laboratory equipment segment in the sexually transmitted disease diagnostics equipment category is expected to 7.1% until 2032.
• In the United States, the market for sexually transmitted disease diagnostics is expected to 2.3 billion US dollars by 2032 with an average annual growth rate of 7.7% throughout the forecast period.
• By 2032, the UK market is expected to be worth 265.1 million US dollarswith an average annual growth rate of 6.7% until 2032.
• With a CAGR of 7.2% During the forecast period, China is expected to reach a market size of 442.0 million US dollars in the diagnosis of sexually transmitted diseases by 2032.
• By 2032, the market for sexually transmitted disease diagnostics in Japan will grow to 356.4 million US dollarsand grows annually by 6.3% until 2032.
• With a CAGR of 5.7% During the forecast period, South Korea is expected to reach a market size of 222.4 million US dollars in the diagnosis of sexually transmitted diseases by 2032.

Sexually Transmitted Disease Diagnostics Market – COMPETITIVE LANDSCAPE:

Major companies profiled in the market report include Abbott Laboratories, Becton Dickinson Company, BioMérieux, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Diasorin Molecular LLC, Hologic, Inc., Orasure Technologies, Inc., Roche Holding AG, and Thermo Fisher Scientific Inc.

Demand for sexually transmitted disease diagnostics is largely concentrated in the North American market due to the availability of sophisticated FDA-approved testing equipment and the widespread use of public health insurance plans that promote health awareness.

Due to the prevalence of sexually transmitted infections in underdeveloped countries and economic prosperity in the Asia-Pacific region, this region is expected to witness significant growth during the forecast period from 2021 to 2028.

Major players in the sexually transmitted disease diagnostics market

• Abbott Laboratories
• Bio-Rad Labs
• Qaigen Inc.
• Diasorin SPA
• MedMira Inc.
• F. Hoffman
• Hologic
• Cepheids
• BioMeriuex

Click here to purchase your full report
https://www.futuremarketinsights.com/checkout/14744

Market segments for the diagnosis of sexually transmitted diseases

By disease types:

• gonorrhea
• syphilis
• Chlamydia
• Herpes simplex virus
• Human papillomaviruses
• Other

Through diagnostic test:

• Cultural/isolated organisms
• Molecular test
• Immunological test
• Other types of tests

By device:

• Thermocycler PCR
• Lateral Flow Reader Immunochromatographic Assays Flow Cytometer
• Absorption microplate readers Enzyme immunoassay
• Other

• Telephone chips
• Portable/Bench
• Diagnostic kits

By location:

By region:

• North America
• Europe
• Asia-Pacific
• Middle East and Africa
• Latin America

author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) has over 12 years of experience in healthcare, medical device and pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying clients’ key challenges and developing robust, hypothesis-based solutions that give them strategic decision-making authority comes naturally to him. His main competencies lie in the areas of market entry and expansion strategies, feasibility studies, competitive analysis and strategic transformation.

Sabyasachi holds a degree in microbiology and is the author of numerous publications and has been cited in peer-reviewed journals including The Journal of mHealth, ITN Online and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award recipient and member of the Greater New York Chamber of Commerce) provides in-depth insights into the driving factors that are driving demand in the market. FMI is the world’s leading provider of market intelligence, advisory services, consulting and events for the packaging, food and beverage, consumer technology, healthcare, industrial and chemical markets. With a huge team of over 400 analysts worldwide, FMI offers global, regional and local expertise on various domains and industry trends in more than 110 countries.

Contact us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
Phone: +1-845-579-5705
For sales inquiries: [email protected]
Website: https://www.futuremarketinsights.com
LinkedIn| Þjórsárdalur| Blog | YouTube